These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 10942095

  • 1. Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
    Rose C, Kamby C, Mouridsen HT, Andersson M, Bastholt L, Møller KA, Andersen J, Munkholm P, Dombernowsky P, Christensen IJ.
    Breast Cancer Res Treat; 2000 May; 61(2):103-10. PubMed ID: 10942095
    [Abstract] [Full Text] [Related]

  • 2. Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.
    Rose C, Kamby C, Mouridsen HT, Bastholt L, Brincker H, Skovgaard-Poulsen H, Andersen AP, Loft H, Dombernowsky P, Andersen KW.
    Breast Cancer Res Treat; 1986 May; 7 Suppl():S45-50. PubMed ID: 3527306
    [Abstract] [Full Text] [Related]

  • 3. Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer.
    Ingle JN, Green SJ, Ahmann DL, Long HJ, Edmonson JH, Rubin J, Chang MN, Creagan ET.
    J Clin Oncol; 1986 Jun; 4(6):958-64. PubMed ID: 3519885
    [Abstract] [Full Text] [Related]

  • 4. Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.
    Ingle JN, Twito DI, Schaid DJ, Cullinan SA, Krook JE, Mailliard JA, Marschke RF, Long HJ, Gerstner JG, Windschitl HE.
    J Clin Oncol; 1988 May; 6(5):825-31. PubMed ID: 3284975
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
    Ingle JN, Suman VJ, Mailliard JA, Kugler JW, Krook JE, Michalak JC, Pisansky TM, Wold LE, Donohue JH, Goetz MP, Perez EA.
    Breast Cancer Res Treat; 2006 Jul; 98(2):217-22. PubMed ID: 16538529
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
    Schmid M, Jakesz R, Samonigg H, Kubista E, Gnant M, Menzel C, Seifert M, Haider K, Taucher S, Mlineritsch B, Steindorfer P, Kwasny W, Stierer M, Tausch C, Fridrik M, Wette V, Steger G, Hausmaninger H.
    J Clin Oncol; 2003 Mar 15; 21(6):984-90. PubMed ID: 12637461
    [Abstract] [Full Text] [Related]

  • 7. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
    Ingle JN, Green SJ, Ahmann DL, Edmonson JH, Nichols WC, Frytak S, Rubin J.
    Cancer Res; 1982 Aug 15; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
    [Abstract] [Full Text] [Related]

  • 8. Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis.
    Ingle JN, Twito DI, Schaid DJ, Cullinan SA, Krook JE, Mailliard JA, Tschetter LK, Long HJ, Gerstner JG, Windschitl HE.
    Cancer; 1991 Feb 15; 67(4):886-91. PubMed ID: 1991261
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma.
    Ingle JN, Suman VJ, Kardinal CG, Krook JE, Mailliard JA, Veeder MH, Loprinzi CL, Dalton RJ, Hartmann LC, Conover CA, Pollak MN.
    Cancer; 1999 Mar 15; 85(6):1284-92. PubMed ID: 10189133
    [Abstract] [Full Text] [Related]

  • 10. Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial.
    Russell CA, Green SJ, O'Sullivan J, Hynes HE, Budd GT, Congdon JE, Martino S, Osborne CK.
    J Clin Oncol; 1997 Jul 15; 15(7):2494-501. PubMed ID: 9215817
    [Abstract] [Full Text] [Related]

  • 11. A randomized phase II trial of aminoglutethimide and hydrocortisone versus combined aminoglutethimide, hydrocortisone and fluoxymesterone in advanced breast cancer.
    Gennatas CS, Kalovidouris A, Paraskevas GA, Kouvaris J, Trichopoulos D, Papavasiliou C.
    Radiother Oncol; 1987 Jul 15; 9(3):217-20. PubMed ID: 3628857
    [Abstract] [Full Text] [Related]

  • 12. Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer.
    Pyrhönen S, Ellmén J, Vuorinen J, Gershanovich M, Tominaga T, Kaufmann M, Hayes DF.
    Breast Cancer Res Treat; 1999 Jul 15; 56(2):133-43. PubMed ID: 10573106
    [Abstract] [Full Text] [Related]

  • 13. Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
    Byrne MJ, Gebski V, Forbes J, Tattersall MH, Simes RJ, Coates AS, Dewar J, Lunn M, Flower C, Gill PG, Stewart J.
    J Clin Oncol; 1997 Sep 15; 15(9):3141-8. PubMed ID: 9294477
    [Abstract] [Full Text] [Related]

  • 14. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
    Friedrichs K, Jänicke F.
    Praxis (Bern 1994); 1998 Apr 22; 87(17):584-8. PubMed ID: 9623325
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
    Pfeiler G, Stöger H, Dubsky P, Mlineritsch B, Singer C, Balic M, Fitzal F, Moik M, Kwasny W, Selim U, Renner K, Ploner F, Steger GG, Seifert M, Hofbauer F, Sandbichler P, Samonigg H, Jakesz R, Greil R, Fesl C, Gnant M, ABCSG.
    Br J Cancer; 2013 Apr 16; 108(7):1408-14. PubMed ID: 23511562
    [Abstract] [Full Text] [Related]

  • 16. Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
    Dubsky PC, Jakesz R, Mlineritsch B, Pöstlberger S, Samonigg H, Kwasny W, Tausch C, Stöger H, Haider K, Fitzal F, Singer CF, Stierer M, Sevelda P, Luschin-Ebengreuth G, Taucher S, Rudas M, Bartsch R, Steger GG, Greil R, Filipcic L, Gnant M.
    J Clin Oncol; 2012 Mar 01; 30(7):722-8. PubMed ID: 22271481
    [Abstract] [Full Text] [Related]

  • 17. Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
    Pritchard KI, Shepherd LE, Chapman JA, Norris BD, Cantin J, Goss PE, Dent SF, Walde D, Vandenberg TA, Findlay B, O'Reilly SE, Wilson CF, Han L, Piura E, Whelan TJ, Pollak MN.
    J Clin Oncol; 2011 Oct 10; 29(29):3869-76. PubMed ID: 21911723
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis.
    Peethambaram PP, Ingle JN, Suman VJ, Hartmann LC, Loprinzi CL.
    Breast Cancer Res Treat; 1999 Mar 10; 54(2):117-22. PubMed ID: 10424402
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer.
    Ingle JN, Suman VJ, Johnson PA, Krook JE, Mailliard JA, Wheeler RH, Loprinzi CL, Perez EA, Jordan VC, Dowsett M.
    Clin Cancer Res; 1999 Jul 10; 5(7):1642-9. PubMed ID: 10430063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.